Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Feb 17;12(1):1078.
doi: 10.1038/s41467-020-20496-3.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Juliette Coignard  1   2   3   4   5   6 Michael Lush  4 Jonathan Beesley  7 Tracy A O'Mara  7 Joe Dennis  4 Jonathan P Tyrer  8 Daniel R Barnes  4 Lesley McGuffog  4 Goska Leslie  4 Manjeet K Bolla  4 Muriel A Adank  9 Simona Agata  10 Thomas Ahearn  11 Kristiina Aittomäki  12 Irene L Andrulis  13   14 Hoda Anton-Culver  15 Volker Arndt  16 Norbert Arnold  17   18 Kristan J Aronson  19 Banu K Arun  20 Annelie Augustinsson  21 Jacopo Azzollini  22 Daniel Barrowdale  4 Caroline Baynes  8 Heiko Becher  23 Marina Bermisheva  24 Leslie Bernstein  25 Katarzyna Białkowska  26 Carl Blomqvist  27   28 Stig E Bojesen  29   30   31 Bernardo Bonanni  32 Ake Borg  33 Hiltrud Brauch  34   35   36 Hermann Brenner  16   36   37 Barbara Burwinkel  38   39 Saundra S Buys  40 Trinidad Caldés  41 Maria A Caligo  42 Daniele Campa  43   44 Brian D Carter  45 Jose E Castelao  46 Jenny Chang-Claude  44   47 Stephen J Chanock  11 Wendy K Chung  48 Kathleen B M Claes  49 Christine L Clarke  50 GEMO Study CollaboratorsEMBRACE CollaboratorsJ Margriet Collée  51 Don M Conroy  8 Kamila Czene  52 Mary B Daly  53 Peter Devilee  54   55 Orland Diez  56   57 Yuan Chun Ding  25 Susan M Domchek  58 Thilo Dörk  59 Isabel Dos-Santos-Silva  60 Alison M Dunning  8 Miriam Dwek  61 Diana M Eccles  62 A Heather Eliassen  63   64 Christoph Engel  65 Mikael Eriksson  52 D Gareth Evans  66   67 Peter A Fasching  68   69 Henrik Flyger  70 Florentia Fostira  71 Eitan Friedman  72   73 Lin Fritschi  74 Debra Frost  4 Manuela Gago-Dominguez  75   76 Susan M Gapstur  45 Judy Garber  77 Vanesa Garcia-Barberan  78 Montserrat García-Closas  11 José A García-Sáenz  78 Mia M Gaudet  45 Simon A Gayther  79 Andrea Gehrig  80 Vassilios Georgoulias  81 Graham G Giles  82   83   84 Andrew K Godwin  85 Mark S Goldberg  86   87 David E Goldgar  88 Anna González-Neira  89 Mark H Greene  90 Pascal Guénel  91 Lothar Haeberle  92 Eric Hahnen  93   94 Christopher A Haiman  95 Niclas Håkansson  96 Per Hall  52   96 Ute Hamann  97 Patricia A Harrington  8 Steven N Hart  98 Wei He  52 Frans B L Hogervorst  9 Antoinette Hollestelle  99 John L Hopper  83 Darling J Horcasitas  100 Peter J Hulick  101   102 David J Hunter  64   103   104 Evgeny N Imyanitov  105 KConFab InvestigatorsHEBON InvestigatorsABCTB InvestigatorsAgnes Jager  99 Anna Jakubowska  26   106 Paul A James  107   108 Uffe Birk Jensen  109 Esther M John  110   111 Michael E Jones  111 Rudolf Kaaks  44 Pooja Middha Kapoor  44   112 Beth Y Karlan  113   114 Renske Keeman  115 Elza Khusnutdinova  24   116 Johanna I Kiiski  117 Yon-Dschun Ko  118 Veli-Matti Kosma  119   120   121 Peter Kraft  64   103 Allison W Kurian  110   111 Yael Laitman  72 Diether Lambrechts  122   123 Loic Le Marchand  124 Jenny Lester  113   114 Fabienne Lesueur  1   2   3   5 Tricia Lindstrom  98 Adria Lopez-Fernández  125 Jennifer T Loud  90 Craig Luccarini  8 Arto Mannermaa  119   120   121 Siranoush Manoukian  22 Sara Margolin  96   126 John W M Martens  99 Noura Mebirouk  1   2   3   5 Alfons Meindl  127 Austin Miller  128 Roger L Milne  82   83   84 Marco Montagna  10 Katherine L Nathanson  58 Susan L Neuhausen  25 Heli Nevanlinna  117 Finn C Nielsen  129 Katie M O'Brien  130 Olufunmilayo I Olopade  131 Janet E Olson  98 Håkan Olsson  21 Ana Osorio  89   132 Laura Ottini  133 Tjoung-Won Park-Simon  59 Michael T Parsons  7 Inge Sokilde Pedersen  134   135   136 Beth Peshkin  137 Paolo Peterlongo  138 Julian Peto  60 Paul D P Pharoah  4   8 Kelly-Anne Phillips  7   83   107 Eric C Polley  98 Bruce Poppe  49 Nadege Presneau  61 Miquel Angel Pujana  139 Kevin Punie  140 Paolo Radice  141 Johanna Rantala  142 Muhammad U Rashid  97   143 Gad Rennert  144 Hedy S Rennert  144 Mark Robson  145 Atocha Romero  146 Maria Rossing  129 Emmanouil Saloustros  147 Dale P Sandler  130 Regina Santella  148 Maren T Scheuner  149 Marjanka K Schmidt  115   150 Gunnar Schmidt  151 Christopher Scott  98 Priyanka Sharma  152 Penny Soucy  153 Melissa C Southey  84   154 John J Spinelli  155   156 Zoe Steinsnyder  157 Jennifer Stone  83   158 Dominique Stoppa-Lyonnet  159   160   161 Anthony Swerdlow  111   162 Rulla M Tamimi  63   64   103 William J Tapper  62 Jack A Taylor  130   163 Mary Beth Terry  148 Alex Teulé  164 Darcy L Thull  165 Marc Tischkowitz  166   167 Amanda E Toland  168 Diana Torres  97   169 Alison H Trainer  108   170 Thérèse Truong  91 Nadine Tung  171 Celine M Vachon  172 Ana Vega  173 Joseph Vijai  145   157 Qin Wang  4 Barbara Wappenschmidt  93   94 Clarice R Weinberg  174 Jeffrey N Weitzel  175 Camilla Wendt  126 Alicja Wolk  176   177 Siddhartha Yadav  178 Xiaohong R Yang  11 Drakoulis Yannoukakos  71 Wei Zheng  179 Argyrios Ziogas  15 Kristin K Zorn  180 Sue K Park  181   182   183 Mads Thomassen  184 Kenneth Offit  145   157 Rita K Schmutzler  93   94 Fergus J Couch  185 Jacques Simard  15 Georgia Chenevix-Trench  7 Douglas F Easton  4   8 Nadine Andrieu  186   187   188   189 Antonis C Antoniou  190
Collaborators, Affiliations
Multicenter Study

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Juliette Coignard et al. Nat Commun. .

Erratum in

  • Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
    Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arnold N, Aronson KJ, Arun BK, Augustinsson A, Azzollini J, Barrowdale D, Baynes C, Becher H, Bermisheva M, Bernstein L, Białkowska K, Blomqvist C, Bojesen SE, Bonanni B, Borg A, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldés T, Caligo MA, Campa D, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chung WK, Claes KBM, Clarke CL; GEMO Study Collaborators; EMBRACE Collaborators; Collée JM, Conroy DM, Czene K, Daly MB, Devilee P, Diez O, Ding YC, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, Garcia-Barberan V, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, Gehrig A, Georgoulias V, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, He W, Hogervorst FBL, Hollestelle A, Hopper JL, Horcasitas DJ, Hu… See abstract for full author list ➔ Coignard J, et al. Nat Commun. 2021 May 14;12(1):2986. doi: 10.1038/s41467-021-23162-4. Nat Commun. 2021. PMID: 33990587 Free PMC article.

Abstract

Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10-8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Case-only sample selection.
Sample selection for a BRCA1 and b BRCA2 case-only analysis. *Four studies were excluded because they were included in clinical trials based on breast tumour characteristics as HER-2 receptor status (see Supplementary Table 2).
Fig. 2
Fig. 2. Control-only sample selection.
Sample selection for a BRCA1 and b BRCA2 control-only analysis.
Fig. 3
Fig. 3. Analytical process for known BC susceptibility SNPs.
Strategy followed for analysing the associations for the 179 known BC susceptibility SNPs.
Fig. 4
Fig. 4. Analytical process for identifying novel modifiers.
Strategy followed for identifying potentially novel SNP modifier.

Similar articles

  • Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
    Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, McGuffog L, Barrowdale D, Dunning AM, Lee A, Dennis J, Healey S, Dicks E, Soucy P, Sinilnikova OM, Pankratz VS, Wang X, Eldridge RC, Tessier DC, Vincent D, Bacot F, Hogervorst FB, Peock S, Stoppa-Lyonnet D; KConFab Investigators; Peterlongo P, Schmutzler RK, Nathanson KL, Piedmonte M, Singer CF, Thomassen M; Ontario Cancer Genetics Network; Hansen Tv, Neuhausen SL, Blanco I, Greene MH, Garber J, Weitzel JN, Andrulis IL, Goldgar DE, D'Andrea E, Caldes T, Nevanlinna H, Osorio A, van Rensburg EJ, Arason A, Rennert G, van den Ouweland AM, van der Hout AH, Kets CM, Aalfs CM, Wijnen JT, Ausems MG; HEBON; EMBRACE; Frost D, Ellis S, Fineberg E, Platte R, Evans DG, Jacobs C, Adlard J, Tischkowitz M, Porteous ME, Damiola F; GEMO Study Collaborators; Golmard L, Barjhoux L, Longy M, Belotti M, Ferrer SF, Mazoyer S, Spurdle AB, Manoukian S, Barile M, Genuardi M, Arnold N, Meindl A, Sutter C, Wappenschmidt B, Domchek SM, Pfeiler G, Friedman E, Jensen UB, Robson M, Shah S, Lazaro C, Mai PL, Benitez J, Southey MC, Schmidt MK, Fasching PA, Peto J, Humphreys MK, Wang Q, Michailidou K, Sawyer EJ, Burwinkel B, Guénel P, Bojesen SE, Milne RL… See abstract for full author list ➔ Gaudet MM, et al. PLoS Genet. 2013;9(3):e1003173. doi: 10.1371/journal.pgen.1003173. Epub 2013 Mar 27. PLoS Genet. 2013. PMID: 23544012 Free PMC article.
  • Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
    Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, Andrulis IL; OCGN; Ozcelik H, Mulligan AM, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Caligo MA, von Wachenfeldt A, Barbany-Bustinza G, Loman N, Soller M, Ehrencrona H, Karlsson P; SWE-BRCA; Nathanson KL, Rebbeck TR, Domchek SM, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Huzarski T, Byrski T, Gronwald J, Cybulski C, Górski B, Osorio A, Durán M, Tejada MI, Benitez J, Hamann U, Hogervorst FB; HEBON; van Os TA, van Leeuwen FE, Meijers-Heijboer HE, Wijnen J, Blok MJ, Kets M, Hooning MJ, Oldenburg RA, Ausems MG, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Jacobs C, Eeles RA, Adlard J, Davidson R, Eccles DM, Cole T, Cook J, Paterson J, Brewer C, Douglas F, Hodgson SV, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Side LE; EMBRACE; Bove B, Godwin AK, Stoppa-Lyonnet D; GEMO Study Collaborators; Fassy-Colcombet M, Castera L, Cornelis F, Mazoyer S, Léoné M, Boutry-Kryza N, Bressac-de Paillerets B, Caron O, Pujol P, Coupier I, Delnatte C, Akloul L, Lynch HT, Snyder CL, Buys SS, … See abstract for full author list ➔ Couch FJ, et al. Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):645-57. doi: 10.1158/1055-9965.EPI-11-0888. Epub 2012 Feb 20. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22351618 Free PMC article.
  • Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
    Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, Dolcetti R, Giannini G, Putignano AL, Varesco L, Radice P, Mai PL, Greene MH, Andrulis IL, Glendon G, Ozcelik H, Thomassen M, Gerdes AM, Kruse TA, Birk Jensen U, Crüger DG, Caligo MA, Laitman Y, Milgrom R, Kaufman B, Paluch-Shimon S, Friedman E, Loman N, Harbst K, Lindblom A, Arver B, Ehrencrona H, Melin B; SWE-BRCA; Nathanson KL, Domchek SM, Rebbeck T, Jakubowska A, Lubinski J, Gronwald J, Huzarski T, Byrski T, Cybulski C, Gorski B, Osorio A, Ramón y Cajal T, Fostira F, Andrés R, Benitez J, Hamann U, Hogervorst FB, Rookus MA, Hooning MJ, Nelen MR, van der Luijt RB, van Os TA, van Asperen CJ, Devilee P, Meijers-Heijboer HE, Gómez Garcia EB; HEBON; Peock S, Cook M, Frost D, Platte R, Leyland J, Evans DG, Lalloo F, Eeles R, Izatt L, Adlard J, Davidson R, Eccles D, Ong KR, Cook J, Douglas F, Paterson J, Kennedy MJ, Miedzybrodzka Z; EMBRACE; Godwin A, Stoppa-Lyonnet D, Buecher B, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Lasset C, Leroux D, Faivre L, Bronner M, Prieur F, Nogues C, Rouleau E, Pujol P, Coupier I… See abstract for full author list ➔ Antoniou AC, et al. Hum Mol Genet. 2011 Aug 15;20(16):3304-21. doi: 10.1093/hmg/ddr226. Epub 2011 May 18. Hum Mol Genet. 2011. PMID: 21593217 Free PMC article.
  • Common genetic variants and cancer risk in Mendelian cancer syndromes.
    Antoniou AC, Chenevix-Trench G. Antoniou AC, et al. Curr Opin Genet Dev. 2010 Jun;20(3):299-307. doi: 10.1016/j.gde.2010.03.010. Curr Opin Genet Dev. 2010. PMID: 20399636 Review.
  • Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.
    Milne RL, Antoniou AC. Milne RL, et al. Endocr Relat Cancer. 2016 Oct;23(10):T69-84. doi: 10.1530/ERC-16-0277. Epub 2016 Aug 15. Endocr Relat Cancer. 2016. PMID: 27528622 Review.

Cited by

References

    1. Ferlay J, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136:E359–E386. - PubMed
    1. Pharoah PDP, Day NE, Duffy S, Easton DF, Ponder BAJ. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int. J. Cancer. 1997;71:800–809. - PubMed
    1. Nelson HD, et al. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann. Intern. Med. 2014;160:255–266. - PubMed
    1. Kuchenbaecker KB, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402–2416. - PubMed
    1. Antoniou AC, et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum. Mol. Genet. 2009;18:4442–4456. - PMC - PubMed

Publication types

Grants and funding